Kinnate Biopharma

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KNTE and other ETFs, options, and stocks.

About KNTE

Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. 

CEO
Nima M. Farzan
CEONima M. Farzan
Employees
61
Employees61
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2018
Founded2018
Employees
61
Employees61

KNTE Key Statistics

Market cap
527.98M
Market cap527.98M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
200.27K
Average volume200.27K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$26.05
52 Week high$26.05
52 Week low
$7.18
52 Week low$7.18

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

KNTE Earnings

-$0.62
-$0.41
-$0.21
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, After Hours
ActualExpected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.